SVCM
Saturn V Capital Management’s Amylyx Pharmaceuticals AMLX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $20.9M | Buy |
3,260,570
+834,134
| +34% | +$5.35M | 8.47% | 3 |
|
|
2025
Q1 | $8.59M | Buy |
2,426,436
+1,537,363
| +173% | +$5.44M | 4.33% | 11 |
|
|
2024
Q4 | $3.36M | Buy |
+889,073
| New | +$3.36M | 1.32% | 19 |
|
|
2024
Q1 | – | Sell |
-1,099,268
| Closed | -$16.2M | – | 23 |
|
|
2023
Q4 | $16.2M | Buy |
1,099,268
+213,125
| +24% | +$3.14M | 6.19% | 7 |
|
|
2023
Q3 | $16.2M | Buy |
+886,143
| New | +$16.2M | 6.79% | 6 |
|